Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 13 Neoplasms 12 Brain Neoplasms 6 Prostatic Neoplasms 5 Neoplasm Metastasis 4 Lung Neoplasms 4 Sarcoma 3 Multiple Myeloma 3 Melanoma 3 Glioblastoma 3 Gastrointestinal Neoplasms 3 Esophageal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 2 Thymus Neoplasms 2 Stomach Neoplasms 2 Sarcoma, Synovial 2 Rectal Neoplasms 2 Pain 2 Ovarian Neoplasms 2 Oligodendroglioma 2 Neuroendocrine Tumors 2 Nasopharyngeal Carcinoma 2 Mesothelioma 2 Liposarcoma 2 Hematologic Neoplasms 2 Head and Neck Neoplasms 2 Glioma 2 Fatigue 2 Colorectal Neoplasms 2

Interventions

Ketamine 4 Surveys and Questionnaires 3 Oxycodone 2 Gabapentin 2 Diclofenac 2 Anesthesia, General 2 Acetaminophen 2 Transcutaneous Electric Nerve Stimulation 1 Tea 1 Ropivacaine 1 Quality of Life 1 Psychotherapy 1 Pregabalin 1 Passive Cutaneous Anaphylaxis 1 Minocycline 1 Meloxicam 1 Lidocaine 1 Ketorolac Tromethamine 1 Ketorolac 1 Ibuprofen 1 Hydromorphone 1 Fentanyl 1 Ethyl Chloride 1 Epinephrine 1 Duloxetine Hydrochloride 1 Diathermy 1 Dexmedetomidine 1 Cryotherapy 1 Control Groups 1 Circumcision, Male 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Acute Pain × Quality of Life × Clear all

NCT02362087 2019-09-06

TAPSOTT14-06

Ottawa Hospital Research Institute

Pain, Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡